Comparable data were obtained after injecting tumor-bearing TRAMP mice with α-GalCer with and without the addition of recombinant IL-12 showing a significant increase of IFNγ serum levels in response to α-GalCer and IL-12 compared to α-GalCer alone (Fig. 5D). The gene discussed is IFNG; the disease is neoplasm.